Original Research

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth

Travanty MN, Calawa B, Shalaby WS, Jozwiakowski MJ, Haraldsen KB

Medical Devices: Evidence and Research 2018, 11:241-252

Published Date: 24 July 2018